AAIC 2025 Abstract
Data‐driven staging of postmortem neuropathology corroborates Braak staging and in‐vivo clinical and cognitive assessments in Alzheimer's’ and Parkinson's diseases
Study in peopleBiomarkers
Abstract
Background: Identifying early biomarkers of neurodegenerative diseases is crucial for early disease intervention. Extending postmortem neuropathology insights to in‐vivo helps link impairment to biomarker accumulation.
